Scholars Central

OpinionPublished 26 Mar 2022

Applications of nanorobotics in vivo and commercialization prospects for clinical uses

Authors: Stephen Ford

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Because of their unique capacity to move and execute complicated tasks at tiny sizes, medical nanorobotics hold a lot of potential for improving medical diagnosis and therapy. Nonetheless, the field's greatest hurdle is its effective translation into broad patient usage. We critically examine the cutting-edge of existing in vivo methods and analyse current and future commercialization prospects. Despite the fact that no "killer application" has yet to emerge to drive quick commercialization, recent technical achievements have resulted in the effective in vivo functioning of medical nanorobots. We also discuss how standardised nanorobotics report summaries is critical not just for improving research quality but also for reducing investment risk in their eventual commercialization.

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nanoscience and Nanomedicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanoscience and Nanomedicine
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Stephen Ford”